The therapy involves transfusing plasma from a patient who has recovered from COVID-19, into a sick patient so that the latter may benefit from the possible antibodies generated in the blood of the patient who has already recovered.
New orders issued by different arms of the Union Health Ministry on plasma therapy for treatment of COVID-19 patients are sending contradictory signals.
According to a report in The Hindu BusinessLine, the latest guidelines issued by the National Blood Transfusion Council (NBTC) states that the use of convalescent plasma for routine treatment of COVID-19 patients is currently not recommended.
This is in ...
Read the full text moneycontrol